Proxsys Rx provides end-to-end solution to help hospitals comply with all 340B program

Proxsys Rx, the nation's largest Integrated Outpatient Pharmacy Provider (IOPP™), now provides an end-to-end solution to hospitals to help them comply with all aspects of the 340B program. Under the federally mandated 340B program, drug makers must provide eligible organizations with certain prescription drugs at significantly reduced prices. These organizations then contract with outpatient pharmacies to dispense the drugs to eligible patients who meet the program's criteria. The 340B Program enables covered entities to make the most of scarce Federal resources in order to provide patients with access to more comprehensive services.

"Hospitals are able to dramatically reduce their 340B costs and enhance proper utilization by implementing Proxsys Rx solutions. They are also partnering with a seasoned team of professionals who have decades of experience navigating the intricacies of the regulatory system," said Proxsys Rx CEO George B. Salem. Transparency and compliance are key benefits of the Proxsys Rx 340B program. The Proxsys Rx model allows the health care facility to better manage 340B operations by reducing the uncertainties related to program participation, cost and pricing that are inherent in similar programs. RxPreferred Benefits provides Proxsys Rx with management support.

Proxsys Rx provides hospitals with robust software tools and pharmacy integration programs to enhance their 340B program status and performance. When a hospital or health care system implements the Proxsys Rx 340B solution, they tap into the program's real time management tools for enrollment, eligibility and crucial reporting that will support the requirements of an audit. Other features include inventory management, invoicing and automated drug replenishment.

Proxsys RX has secured 340B agreements with multiple health care systems as part of their comprehensive pharmacy services package